Putting Research Into Practice
To Improve Patient Care
Talent Isn't Enough
“It doesn‟t matter how talented a doctor is, if he doesn‟t have the right equipment, the right tools, he can‟t perform miracles. That‟s why it‟s so important to have enough funding.”
We’re developing new treatments and surgical techniques that are less invasive, more effective, and make recovery time quicker, bringing better care to our patients.
Nowhere is that statement more evident than in the University of Maryland School of Medicine’s role as an established international leader in biomedical research, fostering the development of innovative treatments for some of today’s biggest health concerns – such as cancer, diabetes, heart disease, stroke, and other neurological disorders.
Professor of Surgery H. Richard Alexander, Jr., MD, and his colleagues performed the first percutaneous hepatic perfusion, a new procedure that targets melanoma that has spread to the liver by delivering a dose of chemotherapy that is 10 times stronger than patients could otherwise tolerate. This could give hope to someone diagnosed with inoperable cancer — by allowing his physicians to apply the cancer-fighting drug only to the liver, thereby reducing the risk of damaging nearby organs, minimizing possible side effects, and improving the way he is able to heal.
Another biomedical breakthrough developed by researchers at the School of Medicine could aid the growing number of people who survive a severe heart attack but go on to face a weak, erratic heartbeat known as ventricular tachycardia. In the effort to find more effective ways to treat the electrical disturbances that cause this potentially life-threatening heart rhythm disorder, Associate Professor of Medicine Timm-Michael L. Dickfeld, MD, PhD and his colleagues have developed a novel 3-D imaging technique that may boost the speed and accuracy of conventional ablation treatments. In other words, by quickly pinpointing the exact spot where the high-energy radio waves are needed, physicians may prevent patients with serious arrhythmias from suffering a repeat heart attack.
By shortening the time needed to propel biomedical innovations from the laboratory to the patient, the School of Medicine continues to be a resource and catalyst for compassionate, leading-edge patient care. This campaign will make certain that we have the critical equipment, technology, facilities, and manpower to carry out the core component of our mission — to heal — by caring for patients wherever they need us.